Probes for the determination of the proclivity for development of autoimmune diseases
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Oct 23, 1990
Grant Date -
N/A
app pub date -
Jul 1, 1986
filing date -
Jul 1, 1986
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
DQ beta gene oligonucleotides selected from the group consisting of (1) GAGAGGAGTACGCACGCTT, (2) GCTGGGGCCGCCTGCCGCC, (3) AGGACCCGGGCGGAGTTGG, (4) GAGAAGAGATCGTGCGCTT, (5) GCTGGGGCTGCCTGCCGCC and (6) AGGAAACGGGCGGCGGTGG. Such oligonucleotides are useful in methods for detecting the proclivity in a human for development of Type I diabetes mellitus.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully